Overview Chemotherapy and G-CSF for Mobilization Status: Recruiting Trial end date: 2024-05-01 Target enrollment: Participant gender: Summary This study aims to demonstrate that the mobilization with cytokine stimulation with G-CSF alone is non-inferior as compared to the standard mobilization with chemotherapy and G-CSF while associated with fewer side effects in myeloma patients. Phase: Phase 2 Details Lead Sponsor: University Hospital Inselspital, BerneTreatments: GemcitabineLenograstimVinblastineVinorelbine